Saturday, January 28, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biosecurity

Medical Countermeasure Consortium Industry Day

by Global Biodefense Staff
October 22, 2015
Joint Project Manager Medical Countermeasure Systems

The U.S. Department of Defense’s Joint Project Manager for Medical Countermeasure Systems (JPM-MCS) will host an Industry Day on 2 Nov. 2015 in Fairfield, NJ.

JPM-MCS is a DoD program within the Joint Program Executive Office for Chemical and Biological Defense. JPM-MCS provides U.S. military forces and the nation with innovative medical solutions to counter chemical, biological, radiological, and nuclear (CBRN) threats.

JPM-MCS focuses on solutions in the following areas:

  • Detection: Systems and devices to identify CBRN agents and assist in making medical decisions
  • Prevention: Prophylaxis, pretreatment, and post-exposure prophylaxis
  • Treatment: Therapeutics (post-exposure, post-symptomatic)
  • Chemical: Medical protection against use of chemical agents

JPM-MCS provided information during a first industry day informing potential offerors of expected research and development tasks under an “Other Transaction Agreement” (OTA) to be awarded for advanced development efforts supporting DoD medical pharmaceutical and diagnostic requirements.

This second industry day aims to provide information on the objectives and requirements of the consortium OTA, and provide any updates based on the information received from attendees at the industry day held in conjunction with BIO 2015 in Philadelphia on 15 June.

At this second industry day, JPM-MCS will request Letters of Intent from those who might form a consortium to determine if and how to move forward.

Advance registration is required.

Tags: Chemical DetectionEventsJPEO-CBRNDRequest for Proposals

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
small glass vials on an assembly line await filling of vaccine solution
Industry News

Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding

January 12, 2023
How Are Bivalent COVID Vaccines Stacking Up Against Omicron?
Infectious Diseases

How Are Bivalent COVID Vaccines Stacking Up Against Omicron?

January 12, 2023
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC